Randomised Controlled Trial of Mycophenolate for Hashimoto Thyroiditis (TRIUMPH)

The Newcastle Upon Tyne Hospitals NHS Foundation TrustcontractContracts FinderRef CF-2834400D0O000000rwimUAASME suitablecomplete
View buyer

Estimated value

£54k

Awarded value

£57k

Awarded 30 Jan 2025

Suppliers

1

Lots

1

1 awarded

Published

30 Jan 2025

Deadline 02 Dec 2024

Other contracts from The Newcastle Upon Tyne Hospitals NHS Foundation Trust· 10

Most recent notices published by the same contracting authority.

View buyer profile →
TitleTypeValuePublished
RNID Near Youcontract21 Apr 2026
Nuffield Health - Surgical Pathways and Diagnostic Imagingcontract21 Apr 2026
Nuffield Health - Surgical Pathways and Diagnostic Imagingcontract07 Apr 2026
EME Maintenance -EMECON0051 - Waters Spectrometer Maintenancecontract04 Feb 2026
Bayer Injectors - Maintenance Contract- 3 Yearscontract£178k29 Jan 2026
Bayer Injectors - Maintenance Contract - 3 Yearscontract£178k29 Jan 2026
Mobile CT Lung Screening Servicecontract22 Jan 2026
IPS & UPS Planned Preventative Maintenancecontract£263k14 Jan 2026
Ways to Wellnesscontract02 Dec 2025
NECTAR Electronic Patient Recordcontract£150k22 Oct 2025

Other contracts awarded to Eramol (UK) Ltd· 10

Cross-buyer view of this supplier's public-sector wins.

View supplier profile →
TitleTypeValuePublished
NHS National Generic Pharmaceuticals - Wave 15ccontract26 Feb 2026
NHS National Generic Pharmaceuticals - Wave 15ccontract14 Jan 2026
Purchase of Placebo and Lansoprazole for TIPAL Projectcontract18 Nov 2025
NHS National Generic Pharmaceuticals Wave 15bcontract04 Aug 2025
Import, labelling, storage and distribution services for Hantavirus vaccinecontract£57k17 Apr 2025
NHS National Generic Pharmaceuticals Wave 15acontract18 Dec 2024
Double Blind Pragmatic Randomised Controlled Trial BOATcontract£312k30 Oct 2024
Double Blind Pragmatic Randomised Controlled Trial (BOAT)contract30 Oct 2024
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)contract£0.0214 May 2024
Lotted Term Framework for the management and manufacture of research drugs including over-labelling, storage and distribution to trial sites, and associated trial monitoring servicescontract01 May 2024